Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 43 citing articles:

SARS-CoV-2: phenotype, genotype, and characterization of different variants
Mohammadreza Saberiyan, Elham Karimi, Zahra Khademi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 40
mRNA: Vaccine or Gene Therapy? The Safety Regulatory Issues
Hélène Banoun
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10514-10514
Open Access | Times Cited: 24
Endothelial Dysfunction in COVID-19: Potential Mechanisms and Possible Therapeutic Options
Maria Chiara Pelle, Isabella Zaffina, Stefania De Luca, et al.
Life (2022) Vol. 12, Iss. 10, pp. 1605-1605
Open Access | Times Cited: 34
A perspective on SARS-CoV-2 virus-like particles vaccines
Gao Xiaoyang, Yeting Xia, Xiaofang Liu, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109650-109650
Open Access | Times Cited: 17
Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3–17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trial
Lidong Gao, Yan Li, Peng He, et al.
The Lancet Child & Adolescent Health (2023) Vol. 7, Iss. 4, pp. 269-279
Open Access | Times Cited: 16
Epidemiology of bacterial respiratory tract infections during the pre-pandemic, COVID-19 pandemic and post-pandemic era: A retrospective study of hospitalized adults in northern Greece between 2018 and 2023
Kyriaki Dimaka, Theodoros Karampatakis, Melina Kachrimanidou, et al.
Diagnostic Microbiology and Infectious Disease (2025) Vol. 111, Iss. 3, pp. 116710-116710
Closed Access
Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review
K. Akash, Avinash Sharma, Deepak Kumar, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4628-4643
Open Access | Times Cited: 22
Trivalent SARS-CoV-2 S1 Subunit Protein Vaccination Induces Broad Humoral Responses in BALB/c Mice
Muhammad S. Khan, Eun Sun Kim, Shaohua Huang, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 314-314
Open Access | Times Cited: 11
Fractionation of sulfated galactan from the red alga Botryocladia occidentalis separates its anticoagulant and anti-SARS-CoV-2 properties
Seon Beom Kim, Mary Zoepfl, Priyanka Samanta, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 5, pp. 101856-101856
Open Access | Times Cited: 17
The impact of maternal SARS-CoV-2 infection and COVID-19 vaccination on maternal-fetal outcomes
Samantha N. Piekos, Nathan D. Price, Leroy Hood, et al.
Reproductive Toxicology (2022) Vol. 114, pp. 33-43
Open Access | Times Cited: 15
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy
Carmela De Marco, Claudia Veneziano, Alice Massacci, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 14
mRNA-LNP COVID-19 vaccine lipids induce low level complement activation and production of proinflammatory cytokines: Mechanisms, effects of complement inhibitors, and relevance to adverse reactions
Tamás Bakos, Tamás Mészáros, Gergely Tibor Kozma, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Interactions between COVID-19 and Lung Cancer: Lessons Learned during the Pandemic
David J. H. Bian, Siham Sabri, Bassam Abdulkarim
Cancers (2022) Vol. 14, Iss. 15, pp. 3598-3598
Open Access | Times Cited: 13
Who Gets Sick From COVID-19? Sociodemographic Correlates of Severe Adult Health Outcomes During Alpha- and Delta-Variant Predominant Periods: September 2020–November 2021
Stanley C. Wei, Dane F. Freeman, Austin Himschoot, et al.
The Journal of Infectious Diseases (2023)
Open Access | Times Cited: 7
Pathogen-host adhesion between SARS-CoV-2 spike proteins from different variants and human ACE2 studied at single-molecule and single-cell levels
Xiaoxu Zhang, Bixia Hong, Peng Wei, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2658-2669
Open Access | Times Cited: 11
mRNA: vaccine or gene therapy? The safety regulatory issues
Hélène Banoun
(2023)
Open Access | Times Cited: 6
A Comprehensive Analysis of Structural and Functional Changes Induced by SARS-CoV-2 Spike Protein Mutations
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
COVID (2023) Vol. 3, Iss. 9, pp. 1454-1472
Open Access | Times Cited: 5
Dynamics of SARS-CoV-2 Spike RBD Protein Mutation and Pathogenicity Consequences in Indonesian Circulating Variants in 2020–2022
Nabiel Muhammad Haykal, Fadilah Fadilah, Beti Ernawati Dewi, et al.
Genes (2024) Vol. 15, Iss. 11, pp. 1468-1468
Open Access | Times Cited: 1
Clinical and epidemiological aspects of Delta and Gamma SARS-CoV-2 variant of concern from the western Brazilian Amazon
Gabriella Sgorlon, Jackson Alves da Silva Queiroz, Tárcio Peixoto Roca, et al.
Memórias do Instituto Oswaldo Cruz (2022) Vol. 117
Open Access | Times Cited: 8
Potential of Endogenous Oxytocin in Endocrine Treatment and Prevention of COVID-19
Stephani C. Wang, Fengmin Zhang, Hui Zhu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 7
Risk of death, hospitalization and intensive care unit admission by SARS-CoV-2 variants in Peru: a retrospective study
Diego Fano-Sizgorich, Cinthya Vásquez‐Velásquez, Laura R. Orellana, et al.
International Journal of Infectious Diseases (2022) Vol. 127, pp. 144-149
Open Access | Times Cited: 7
Review of Clinical Trials of COVID-19 Vaccination Booster in SARS-CoV-2 Variants Era: To Take It or Not To Take It
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Frontiers in Drug Discovery (2022) Vol. 2
Open Access | Times Cited: 6
Clinical and Virological Features of Patients Hospitalized with Different Types of COVID-19 Vaccination in Mexico City
Alejandra Hernández‐Terán, Pamela Garcíadiego-Fossas, Marco Villanueva-Reza, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1181-1181
Open Access | Times Cited: 4
Comparison of Intracellular Transcriptional Response of NHBE Cells to Infection with SARS-CoV-2 Washington and New York Strains
Tiana M. Scott, Antonio Solis‐Leal, Jean-Baptiste Lopez, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 4
The effectiveness of COVID-19 vaccination in preventing hospitalisation and mortality: A nationwide cross-sectional study in Iran
Mahya Razimoghadam, Rajabali Daroudi, Mehdi Yaseri
Journal of Global Health (2024) Vol. 14
Open Access
Page 1 - Next Page

Scroll to top